Intervention:   selumetinib          

    Access protocols via the Procedure column.
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Wiltshire4 52461 immune cell quantification selumetinib B cells, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    Wiltshire4 52467 immune cell quantification selumetinib T cells, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    Wiltshire4 52473 immune cell quantification selumetinib monocytes, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    All boxes